AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8295245 — intervention group
Group type: EXPERIMENTAL
Intervention: Nystatin 2 million units every 6 hours
Number of subjects: 292
Study 8295245 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 292
Study 3389331 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) at doses of 100, 200, and 300 kcal
Number of subjects: 0
Study 3389331 — intervention group
Group type: COMPARATOR
Intervention: Long-chain triglycerides (LCT)
Number of subjects: 0
Study 30572528 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl patch (TFP) 25 μg/h
Number of subjects: 60
Study 30572528 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fentanyl infusion (IV) 25 μg/h
Number of subjects: 60
Study 30572528 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (TFP and IV)
Number of subjects: 60
Study 27100286 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-Based Learning (TBL) module
Number of subjects: 99
Study 24919102 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training program in public parks (6 weeks, 2 sessions/week, 12 exercises/session, 50 min)
Number of subjects: 28
Study 24919102 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training program in public parks
Number of subjects: 28
Study 23151009 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated working with NHS services
Number of subjects: 621
Study 23151009 — intervention group
Group type: EXPERIMENTAL
Intervention: Care homes working with multiple general practices
Number of subjects: 621
Study 23151009 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional services visiting care homes
Number of subjects: 621
Study 23151009 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of care services
Number of subjects: 621
Study 23151009 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential for improved quality of care
Number of subjects: 621
Study 20954214 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of ondansetron (8 mg)
Number of subjects: 25
Study 18458658 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 64
Study 18458658 — intervention group
Group type: COMPARATOR
Intervention: Continuous indomethacin
Number of subjects: 64
Study 15681957 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at a mean rate of 0.17 mug . kg . min
Number of subjects: 60
Study 15681957 — intervention group
Group type: COMPARATOR
Intervention: 70% nitrous oxide
Number of subjects: 60
Study 15681957 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 60
Study 15829860 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive addition lenses (PALs) with +2.00 D near addition
Number of subjects: 469
Study 15829860 — intervention group
Group type: COMPARATOR
Intervention: Single-vision lenses (SVLs)
Number of subjects: 469
Study 11505347 — intervention group
Group type: EXPERIMENTAL
Intervention: Target-controlled infusion (TCI) of propofol (plasma target concentration, 2 to 3 microg x mL; n = 10)
Number of subjects: 20
Study 11505347 — intervention group
Group type: COMPARATOR
Intervention: Manually controlled infusion (MCI) of propofol (2.5 to 3.5 mg/kg/hr; n = 10)
Number of subjects: 20
Study 9262266 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrashort gonadotrophin-releasing hormone agonist protocol
Number of subjects: 60
Study 9262266 — intervention group
Group type: COMPARATOR
Intervention: Modified suppression gonadotrophin-releasing hormone agonist protocol
Number of subjects: 60
Study 8486173 — intervention group
Group type: COMPARATOR
Intervention: 4 or 8 mg of oral E2 and vaginal ultrasound (US) daily until endometrial thickness > or = 6 mm with a triple‐line pattern
Number of subjects: 12
Study 8486173 — intervention group
Group type: EXPERIMENTAL
Intervention: US monitoring of endometrial development during estrogen (E) administration
Number of subjects: 12
Study 3567045 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg once daily
Number of subjects: 24
Study 3567045 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg once daily
Number of subjects: 24
Study 3567045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 2547137 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic oestradiol valerate plus cyproterone acetate (E2V + CPA)
Number of subjects: 86
Study 2547137 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous 17 beta-oestradiol plus norethisterone acetate (E2 + NETA)
Number of subjects: 86
Study 2547137 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 2547137 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of hormone therapy
Number of subjects: 86
Study 30863080 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate 3-month (PP3M)
Number of subjects: 995
Study 30863080 — intervention group
Group type: COMPARATOR
Intervention: Paliperidone palmitate 1-month (PP1M)
Number of subjects: 995
Study 28486381 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Foley and oxytocin
Number of subjects: 323
Study 28486381 — intervention group
Group type: COMPARATOR
Intervention: Foley followed by oxytocin
Number of subjects: 323
Study 28486381 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 323
Study 25797871 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 20
Study 25797871 — intervention group
Group type: COMPARATOR
Intervention: CERA (Epoetin Beta pegol)
Number of subjects: 20
Study 23313969 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3 mg)
Number of subjects: 76
Study 23313969 — intervention group
Group type: COMPARATOR
Intervention: Ramosetron plus Dexamethasone (8 mg + 0.3 mg)
Number of subjects: 76
Study 21306837 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing plus feedback and skills building (MI+)
Number of subjects: 54
Study 21306837 — intervention group
Group type: EXPERIMENTAL
Intervention: Video information plus debriefing (Video+)
Number of subjects: 54
Study 19634969 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 180
Study 19634969 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant medications
Number of subjects: 180
Study 16761228 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium bromide 18 microg once daily
Number of subjects: 1639
Study 16761228 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium bromide
Number of subjects: 1639
Study 15793055 — intervention group
Group type: EXPERIMENTAL
Intervention: Low prime volume pump (LPVP)
Number of subjects: 14
Study 15793055 — intervention group
Group type: COMPARATOR
Intervention: Normal prime volume CPB (Group N)
Number of subjects: 14
Study 11213955 — intervention group
Group type: EXPERIMENTAL
Intervention: Nausea and vomiting
Number of subjects: 431
Study 11213955 — intervention group
Group type: EXPERIMENTAL
Intervention: Irritability
Number of subjects: 431
Study 11213955 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased level of consciousness (LOC)
Number of subjects: 431
Study 11213955 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythema
Number of subjects: 431
Study 11213955 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulging fontanelle
Number of subjects: 431
Study 11213955 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss of developmental milestones (late encounters)
Number of subjects: 431
Study 11213955 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased LOC (late encounters)
Number of subjects: 431
Study 11213955 — intervention group
Group type: EXPERIMENTAL
Intervention: Shunt score (early encounters)
Number of subjects: 431
Study 11213955 — intervention group
Group type: EXPERIMENTAL
Intervention: Shunt score (late encounters)
Number of subjects: 431
Study 9200849 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to pseudocumene, mesitylene, or hemimellitene at concentrations ranging from 5 to 150 mg/m3 air.
Number of subjects: 8
Study 9200849 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to TMB at various concentrations.
Number of subjects: 8
Study 9200849 — intervention group
Group type: EXPERIMENTAL
Intervention: TMB exposure and its metabolites in biological fluids.
Number of subjects: 8
Study 9200849 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed biological exposure limit (BEL) for TMB.
Number of subjects: 8
Study 8197906 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable pins with x-ray opaque markers (Polypin)
Number of subjects: 57
Study 2906453 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg mifentidine
Number of subjects: 9
Study 2906453 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg mifentidine
Number of subjects: 9
Study 2906453 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 30623268 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal orthosis
Number of subjects: 113
Study 30623268 — intervention group
Group type: EXPERIMENTAL
Intervention: Equipment training
Number of subjects: 113
Study 30623268 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 113
Study 28535474 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Navigator Program (PNP)
Number of subjects: 0
Study 26256990 — intervention group
Group type: COMPARATOR
Intervention: Control group (ventilation with a tidal volume of 8 mL/kg)
Number of subjects: 99
Study 26256990 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP group (ventilation with a tidal volume of 6 mL/kg and PEEP of 8 cm H₂O)
Number of subjects: 99
Study 26256990 — intervention group
Group type: EXPERIMENTAL
Intervention: AR group (alveolar recruitment maneuver followed by PEEP of 8 cm H₂O)
Number of subjects: 99
Study 22855267 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyurethane foam (PU) with 55% polyethylene glycol (PEG)
Number of subjects: 2
Study 22855267 — intervention group
Group type: COMPARATOR
Intervention: Collagen
Number of subjects: 2
Study 22855267 — intervention group
Group type: COMPARATOR
Intervention: Gelatin
Number of subjects: 2
Study 20809091 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL)
Number of subjects: 46
Study 20809091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 18509179 — intervention group
Group type: EXPERIMENTAL
Intervention: Valspodar (PSC 833) 5 mg/kg every 6 hours for 12 doses, paclitaxel 80 mg/m(2), and carboplatin AUC 6 (PC-PSC)
Number of subjects: 762
Study 18509179 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel 175 mg/m(2) and carboplatin AUC 6 (PC)
Number of subjects: 762
Study 18509179 — intervention group
Group type: EXPERIMENTAL
Intervention: Valspodar (PSC 833) combined with paclitaxel and carboplatin (PC-PSC)
Number of subjects: 762
Study 18509179 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel and carboplatin (PC)
Number of subjects: 762
Study 16781225 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ) 40 mg TID
Number of subjects: 10
Study 16781225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12925096 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-vaccinated children
Number of subjects: 207
Study 12925096 — intervention group
Group type: EXPERIMENTAL
Intervention: Children vaccinated with pertussis toxoid
Number of subjects: 207
Study 12925096 — intervention group
Group type: EXPERIMENTAL
Intervention: Adults
Number of subjects: 207
Study 10893651 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.4 mg/day
Number of subjects: 211
Study 10893651 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.2 mg/day
Number of subjects: 211
Study 8840357 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 0
Study 8840357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1900014 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation to a mean PaCO2 of 3.3 kPa (Group I)
Number of subjects: 30
Study 1900014 — intervention group
Group type: COMPARATOR
Intervention: Normocapnia with a mean PaCO2 of 5.3 kPa (Group II)
Number of subjects: 30
Study 6131448 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (7 mg/kg)
Number of subjects: 15
Study 6131448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 6131448 — intervention group
Group type: EXPERIMENTAL
Intervention: Crotylbarbital (2 mg/kg)
Number of subjects: 15
Study 30782716 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated oxygen administration (FreeO2 group)
Number of subjects: 0
Study 30782716 — intervention group
Group type: COMPARATOR
Intervention: Conventional oxygen therapy (Standard group)
Number of subjects: 0
Study 29413361 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA+EPA 750mg/day
Number of subjects: 36
Study 29413361 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA+EPA 1000mg/day
Number of subjects: 36
Study 27244706 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Mentors (PMs)
Number of subjects: 237
Study 24918373 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodalumab 140 mg
Number of subjects: 168
Study 24918373 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodalumab 280 mg
Number of subjects: 168
Study 24918373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 24918373 — intervention group
Group type: COMPARATOR
Intervention: Placebo to open-label brodalumab
Number of subjects: 168
Study 24918373 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodalumab groups
Number of subjects: 168
Study 24918373 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 168
Study 22851684 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple stenting strategy
Number of subjects: 500
Study 22851684 — intervention group
Group type: COMPARATOR
Intervention: Complex stenting strategy
Number of subjects: 500
Study 22851684 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin use in simple stenting strategy
Number of subjects: 500
Study 22851684 — intervention group
Group type: COMPARATOR
Intervention: Troponin use in complex stenting strategy
Number of subjects: 500
Study 22851684 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin use overall
Number of subjects: 500
Study 19902267 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination steroid and mizoribine (MZB) therapy (4-5 mg/kg/day)
Number of subjects: 57
Study 19902267 — intervention group
Group type: COMPARATOR
Intervention: Steroid only therapy
Number of subjects: 57
Study 18304050 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 120
Study 18304050 — intervention group
Group type: COMPARATOR
Intervention: Promethazine 25 mg
Number of subjects: 120
Study 15749143 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented milk containing Lactobacillus casei
Number of subjects: 99
Study 15749143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 11928179 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (300 mg)
Number of subjects: 12
Study 11928179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 10424380 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel applied by interdental flossing
Number of subjects: 21
Study 10424380 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel applied using individually designed mouth trays
Number of subjects: 21
Study 10424380 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel applied by a combination of polishing and flossing
Number of subjects: 21
Study 10424380 — intervention group
Group type: COMPARATOR
Intervention: Flossing alone
Number of subjects: 21
Study 8567877 — intervention group
Group type: EXPERIMENTAL
Intervention: BACTEC 9240 Aerobic/F resin bottle
Number of subjects: 520
Study 8567877 — intervention group
Group type: COMPARATOR
Intervention: Isolator system
Number of subjects: 520
Study 2116808 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of gamma‐glutamyl‐L‐dopa (25 micrograms/kg/min) for 10 h
Number of subjects: 0
Study 2116808 — intervention group
Group type: COMPARATOR
Intervention: Oral dosing of gludopa
Number of subjects: 0
Study 361362 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral aromatic retinoid (1.0 mg/kg body-weight)
Number of subjects: 134
Study 361362 — intervention group
Group type: COMPARATOR
Intervention: Photochemotherapy alone (Control)
Number of subjects: 134
Study 361362 — intervention group
Group type: EXPERIMENTAL
Intervention: Photochemotherapy with retinoid
Number of subjects: 134
Study 361362 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard photochemotherapy maintenance treatment
Number of subjects: 134
Study 31174347 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary Guideline Index (DGI) applied to weighed food records (WFR)
Number of subjects: 141
Study 28664834 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg twice daily
Number of subjects: 520
Study 28664834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520
Study 25600572 — intervention group
Group type: EXPERIMENTAL
Intervention: DFP and DFX
Number of subjects: 96
Study 25600572 — intervention group
Group type: COMPARATOR
Intervention: DFP and DFO
Number of subjects: 96
Study 25600572 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 96
Study 23659394 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 µg/kg dexmedetomidine (Group D(2))
Number of subjects: 87
Study 23659394 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 µg/kg dexmedetomidine (Group D(1))
Number of subjects: 87
Study 23659394 — intervention group
Group type: COMPARATOR
Intervention: Saline (Group C)
Number of subjects: 87
Study 21040180 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up phone calls
Number of subjects: 63
Study 21040180 — intervention group
Group type: COMPARATOR
Intervention: No phone call (control)
Number of subjects: 63
Study 18412642 — intervention group
Group type: EXPERIMENTAL
Intervention: High end-tidal carbon dioxide (3-12 kPa)
Number of subjects: 24
Study 18412642 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal end-tidal carbon dioxide (3-12 kPa)
Number of subjects: 24
Study 18412642 — intervention group
Group type: EXPERIMENTAL
Intervention: Low end-tidal carbon dioxide (3-12 kPa)
Number of subjects: 24
Study 16988273 — intervention group
Group type: EXPERIMENTAL
Intervention: DDM-ME TRAP regimen
Number of subjects: 16
Study 16988273 — intervention group
Group type: EXPERIMENTAL
Intervention: DDM-CS regimen
Number of subjects: 16
Study 16988273 — intervention group
Group type: COMPARATOR
Intervention: Control group (unvaccinated)
Number of subjects: 16
Study 12966663 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical management with improved perioperative management and advanced cardiopulmonary bypass technology
Number of subjects: 0
Study 12966663 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term follow-up assessment
Number of subjects: 0
Study 12966663 — intervention group
Group type: EXPERIMENTAL
Intervention: Future surgical techniques
Number of subjects: 0
Study 10985138 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (25,000 IU of retinyl palmitate on study days 1, 4, and 8)
Number of subjects: 130
Study 10985138 — intervention group
Group type: COMPARATOR
Intervention: Placebo (similar appearance to vitamin A drops)
Number of subjects: 130
Study 10985138 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 130
Study 1639053 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium-rich bread (200 micrograms Se) for 6 weeks
Number of subjects: 12
Study 1639053 — intervention group
Group type: COMPARATOR
Intervention: Low-Se bread (control)
Number of subjects: 12
Study 6375599 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime 1 day (1.5 g every 8 hours, starting 1 hour before surgery)
Number of subjects: 211
Study 6375599 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime 3 days (1.5 g every 8 hours, starting 1 hour before surgery)
Number of subjects: 211
Study 6375599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211
Study 30736770 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printing model (n = 23)
Number of subjects: 48
Study 30736770 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (n = 25)
Number of subjects: 48
Study 29781884 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 100
Study 29781884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 26645159 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection (USGI) of corticosteroids (20mg of methylprednisolone acetate)
Number of subjects: 114
Study 26645159 — intervention group
Group type: COMPARATOR
Intervention: Conventional blind injection (CBI) of corticosteroids (20mg of methylprednisolone acetate)
Number of subjects: 114
Study 24790422 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 20
Study 24790422 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 20
Study 24790422 — intervention group
Group type: COMPARATOR
Intervention: Combined (collapsed by group)
Number of subjects: 20
Study 22448810 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg plus mosapride 5 mg
Number of subjects: 10
Study 22448810 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg alone
Number of subjects: 10
Study 20429492 — intervention group
Group type: EXPERIMENTAL
Intervention: Story Sharing (StS)
Number of subjects: 0
Study 20429492 — intervention group
Group type: COMPARATOR
Intervention: Communication Skills
Number of subjects: 0
Study 17920731 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV‐1 DNA vaccine
Number of subjects: 31
Study 17920731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 16132246 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin therapy (initiated on postoperative day 4)
Number of subjects: 72
Study 16132246 — intervention group
Group type: COMPARATOR
Intervention: Dietary therapy alone (control group)
Number of subjects: 72
Study 11881315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg) administered orally 12 and 2 hours before surgery, and every 8 hours until the third postoperative day.
Number of subjects: 20
Study 11881315 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ibuprofen treatment).
Number of subjects: 20